ConductScience.org, home

Paper28677828

Vortioxetine for depression in adults.

Koesters M and 4 others. Cochrane Database Syst Rev, 2017. Cited by 41 papers, by iCite.

Cite this record

ConductScience Library. Vortioxetine for depression in adults. Papers, record 28677828. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28677828

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Vortioxetine for depression in adults.
PubMed
Journal
Cochrane Database Syst Rev
PubMed
Year
2017
PubMed
Publication types
Journal Article, Meta-Analysis, Systematic Review
PubMed
Citations, by iCite
41
iCite
Relative citation ratio, by iCite
2.07
iCite
Revised in PubMed
2026-01-27
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Koesters MMarkus
2Ostuzzi GGiovanni
3Guaiana GGiuseppe
4Breilmann JJohanna
5Barbui CCorrado

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antidepressive AgentsMajor topic
Major Depressive DisorderMajor topic
PiperazinesMajor topic
SulfidesMajor topic
Adult
Duloxetine Hydrochloride
Humans
Patient Dropouts
Placebos
Randomized Controlled Trials as Topic
Remission Induction
Serotonin and Noradrenaline Reuptake Inhibitors
Venlafaxine Hydrochloride
Vortioxetine

Source PubMed

Download CSV of topics

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT05866575Prediction of the Therapeutic Response in Depression Based on Neuro-computational Modeling Assessment of MotivationBackground

Source ClinicalTrials.gov

Download CSV of trials

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Comment in30264702Network meta-analysis of antidepressants.https://conductscience.org/library/papers/30264702

Source PubMed

Download CSV of comments and corrections

References61

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
126122791Modes and nodes explain the mechanism of action of vortioxetine, a multimodal agent (MMA): blocking 5HT3 receptors enhances release of serotonin, norepinephrine, and acetylcholine.CNS Spectr2015https://conductscience.org/library/papers/26122791PubMed
224871704The efficacy and safety of 5 mg/d Vortioxetine compared to placebo for major depressive disorder: A meta-analysis.Psychopharmacology (Berl)2015https://conductscience.org/library/papers/24871704PubMed
324464277Converting an odds ratio to a range of plausible relative risks for better communication of research findings.BMJ2014https://conductscience.org/library/papers/24464277PubMed
423245607Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010.Lancet2012https://conductscience.org/library/papers/23245607PubMed
522214892Out of sight but not out of mind: how to search for unpublished clinical trial evidence.BMJ2012https://conductscience.org/library/papers/22214892PubMed
622495621A randomized clinical study of Lu AA21004 in the prevention of relapse in patients with major depressive disorder.J Psychopharmacol2012https://conductscience.org/library/papers/22495621PubMed
722147715Comparative benefits and harms of second-generation antidepressants for treating major depressive disorder: an updated meta-analysis.Ann Intern Med2011https://conductscience.org/library/papers/22147715PubMed
821767441A double-blind, randomized, placebo-controlled, active reference study of Lu AA21004 in patients with major depressive disorder.Int J Neuropsychopharmacol2012https://conductscience.org/library/papers/21767441PubMed
915602117Imputing response rates from means and standard deviations in meta-analyses.Int Clin Psychopharmacol2005https://conductscience.org/library/papers/15602117PubMed
1024059250Assessing and presenting summaries of evidence in Cochrane Reviews.Syst Rev2013https://conductscience.org/library/papers/24059250PubMed
1118303940Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration.PLoS Med2008https://conductscience.org/library/papers/18303940PubMed
129522799Interpreting treatment effects in randomised trials.BMJ1998https://conductscience.org/library/papers/9522799PubMed
1326035185A randomized, double-blind, placebo-controlled study of the efficacy and safety of vortioxetine 10 mg and 20 mg in adults with major depressive disorder.J Clin Psychiatry2015https://conductscience.org/library/papers/26035185PubMed
1423857675Preliminary study of patterns of medication use for depression treatment in China.Asia Pac Psychiatry2013https://conductscience.org/library/papers/23857675PubMed
1520831742A systematic review of duloxetine and venlafaxine in major depression, including unpublished data.Acta Psychiatr Scand2011https://conductscience.org/library/papers/20831742PubMed
1624787143A randomized, double-blind, placebo-controlled study of vortioxetine on cognitive function in depressed adults.Int J Neuropsychopharmacol2014https://conductscience.org/library/papers/24787143PubMed
1711914297Can we individualize the 'number needed to treat'? An empirical study of summary effect measures in meta-analyses.Int J Epidemiol2002https://conductscience.org/library/papers/11914297PubMed
185009428Diagnostic criteria for use in psychiatric research.Arch Gen Psychiatry1972https://conductscience.org/library/papers/5009428PubMed
1923357658What does the HAMD mean?J Affect Disord2013https://conductscience.org/library/papers/23357658PubMed
2027013879The efficacy and safety of 10 mg vortioxetine in the treatment of major depressive disorder: a meta-analysis of randomized controlled trials.Neuropsychiatr Dis Treat2016https://conductscience.org/library/papers/27013879PubMed

See all 61 referencesDownload CSV of references

Cited by27

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 41 citations.

PMIDTitleJournalYearIn PapersSource
39649121Recent Advances in the Psychopharmacology of Major Depressive Disorder.BJPsych Adv2023https://conductscience.org/library/papers/39649121PubMed
39487479Effectiveness of 8-week TReatment with vortioxetine on depressive symptoms in major depressive disorder patients with comorbid generalized anxiety disorder in UAE (TRUE).Ann Gen Psychiatry2024https://conductscience.org/library/papers/39487479PubMed
38869643Depression and anxiety in multiple sclerosis. Review of a fatal combination.J Neural Transm (Vienna)2024https://conductscience.org/library/papers/38869643PubMed
37922101SSRIs in the Treatment of Depression: A Pharmacological CUL-DE-SAC?Curr Top Behav Neurosci2024https://conductscience.org/library/papers/37922101PubMed
37626556Depression and Pseudodementia: Decoding the Intricate Bonds in an Italian Outpatient Setting.Brain Sci2023https://conductscience.org/library/papers/37626556PubMed
37513187Coriandrum sativum and Its Utility in Psychiatric Disorders.Molecules2023https://conductscience.org/library/papers/37513187PubMed
37046135Designing Clinical Trials to Assess the Impact of Pharmacological Treatment for Suicidal Ideation/Behavior: Issues and Potential Solutions.Pharmaceut Med2023https://conductscience.org/library/papers/37046135PubMed
36387336Real-world pharmacological treatment of patients with postpartum depression in China from 2016 to 2020: A cross-sectional analysis.Saudi Pharm J2022https://conductscience.org/library/papers/36387336PubMed
36358393Vortioxetine Improves Depressive Symptoms and Cognition in Parkinson's Disease Patients with Major Depression: An Open-Label Prospective Study.Brain Sci2022https://conductscience.org/library/papers/36358393PubMed
35955946The Implication of 5-HT Receptor Family Members in Aggression, Depression and Suicide: Similarity and Difference.Int J Mol Sci2022https://conductscience.org/library/papers/35955946PubMed
35815048Systematic Review and Meta-Analysis of Vortioxetine for the Treatment of Major Depressive Disorder in Adults.Front Psychiatry2022https://conductscience.org/library/papers/35815048PubMed
35740340Inhibitory Effectiveness in Delayed-Rectifier Potassium Current Caused by Vortioxetine, Known to Be a Novel Antidepressant.Biomedicines2022https://conductscience.org/library/papers/35740340PubMed
35272591Differential Response to Three Antidepressants in Patients with Major Depressive Episode Who Suffered Covid-19-Related Trauma.Curr Neuropharmacol2022https://conductscience.org/library/papers/35272591PubMed
35020178Post-Marketing Safety Profile of Vortioxetine Using a Cluster Analysis and a Disproportionality Analysis of Global Adverse Event Reports.Drug Saf2022https://conductscience.org/library/papers/35020178PubMed
35015359The efficacy of psychotherapies and pharmacotherapies for mental disorders in adults: an umbrella review and meta-analytic evaluation of recent meta-analyses.World Psychiatry2022https://conductscience.org/library/papers/35015359PubMed
34888167G-protein coupled receptors and synaptic plasticity in sleep deprivation.World J Psychiatry2021https://conductscience.org/library/papers/34888167PubMed
34681209Rediscovering Psilocybin as an Antidepressive Treatment Strategy.Pharmaceuticals (Basel)2021https://conductscience.org/library/papers/34681209PubMed
34252320Key considerations in the pharmacological management of treatment-resistant depression.Expert Opin Pharmacother2021https://conductscience.org/library/papers/34252320PubMed
34211395Hippocampal PPARα Plays a Role in the Pharmacological Mechanism of Vortioxetine, a Multimodal-Acting Antidepressant.Front Pharmacol2021https://conductscience.org/library/papers/34211395PubMed
33971984Cross-sectional study of medical advertisements in a national general medical journal: evidence, cost, and safe use of advertised versus comparative drugs.Res Integr Peer Rev2021https://conductscience.org/library/papers/33971984PubMed

See all 27 cited byDownload CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
SLC6A46532PubTator's text mininghttps://conductscience.org/library/genes/6532

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/28677828

GET https://conductscience.org/api/papers/v1/28677828/references?page=2